We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer

This study is currently recruiting participants.
Verified June 2017 by University of Washington
Sponsor:
ClinicalTrials.gov Identifier:
NCT02157051
First Posted: June 5, 2014
Last Update Posted: June 22, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
United States Department of Defense
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Washington
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2022
  Estimated Primary Completion Date: February 2022 (Final data collection date for primary outcome measure)